Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.4
3.9
Journals
JCM
Special Issues
Recent Advances in Transcatheter Aortic Valve Replacement
share announcement

Recent Advances in Transcatheter Aortic Valve Replacement

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 10 September 2024 | Viewed by 2530

Special Issue Editors

Dr. Maciej Dąbrowski

E-Mail Website
Guest Editor
Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland
Interests: coronary angioplasty; aortic stenosis; transcatheter aortic valve implantation; hypertrophic cardiomyopathy
Dr. Anna Olasińska-Wiśniewska

E-Mail Website
Guest Editor
Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, 61-848 Poznan, Poland
Interests: aortic stenosis; transcatheter aortic valve implantation; heart failure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Transcatheter aortic valve replacement (TAVI) has evolved rapidly since the first procedure in 2002. Currently, TAVI is the recommended method of treatment for patients with severe aortic stenosis with moderate to high surgical risk, in addition to some selected low-risk patients. Diagnostic modalities support the proper qualification for the procedure. Modifications of the technique, bioprostheses and delivery systems enable operators to perform the procedure relatively safely, even in particularly difficult clinical scenarios. Nevertheless, several troublesome issues may occur during or after the procedure. The aim of this Special Issue is to share experiences in pre-procedural planning, procedural techniques and post-procedural outcomes in order to broaden the knowledge on TAVI performance and improve TAVI team skills. 

We invite authors to share their valuable opinions and the results of their research as original or review papers. We would be very grateful for your outstanding contribution to the further development of TAVI.

Dr. Maciej Dąbrowski
Dr. Anna Olasińska-Wiśniewska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aortic stenosis
  • transcatheter
  • bioprosthesis
  • TAVI
  • Transcatheter aortic valve replacement

Published Papers (3 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Other

12 pages, 1278 KiB  
Article
Short-Term Changes in Arterial Stiffness Measured by 2D Speckle Tracking in Patients Undergoing Transcatheter Aortic Valve Implantation
by Leonie Arnold, Nikolaus Alexander Haas, André Jakob, Julius Fischer, Steffen Massberg, Simon Deseive and Felix Sebastian Oberhoffer
J. Clin. Med. 2024, 13(1), 222; https://doi.org/10.3390/jcm13010222 - 30 Dec 2023
Viewed by 541
Abstract
Arterial stiffness has received increasing interest as a cardiovascular marker in patients with aortic valve stenosis (AS). So far, studies on the impact of aortic valve replacement (AVR) on arterial stiffness have been equivocal. Two-dimensional speckle tracking (2DST) is a novel, non-invasive method [...] Read more.
Arterial stiffness has received increasing interest as a cardiovascular marker in patients with aortic valve stenosis (AS). So far, studies on the impact of aortic valve replacement (AVR) on arterial stiffness have been equivocal. Two-dimensional speckle tracking (2DST) is a novel, non-invasive method to measure the motion of the vessel wall. In this prospective observational study, we aimed to assess the change in arterial stiffness of the common carotid artery (CCA) measured by 2DST in patients undergoing transcatheter aortic valve implantation (TAVI). A total of 47 patients were included in the study (age 80.04 ± 6.065 years). Peak circumferential strain (CS) was significantly improved after TAVI (4.50 ± 2.292 vs. 5.12 ± 2.958, p = 0.012), as was the peak strain rate (CSR) (0.85 ± 0.567 vs. 1.35 ± 0.710, p = 0.002). Body mass index (BMI), mean arterial pressure (MAP) and hemodynamic parameters were associated with this change. 2DST results did not correlate with aortic pulse wave velocity (aPWV) or augmentation index normalized to heart rate (AIx@75), suggesting a distinct difference between arterial stiffness of the CCA and other stiffness parameters. 2DST seems to be a promising new tool to assess arterial stiffness in TAVI patients. Full article
(This article belongs to the Special Issue Recent Advances in Transcatheter Aortic Valve Replacement)
►▼ Show Figures

Figure 1

11 pages, 1082 KiB  
Article
Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity-Matched Study
by Jonathan Halim, Maxim Rooijakkers, Peter den Heijer, Milad El Haddad, Ben van den Branden, Jeroen Vos, Bas Schölzel, Martijn Meuwissen, Menno van Gameren, Saloua El Messaoudi, Niels van Royen and Sander IJsselmuiden
J. Clin. Med. 2023, 12(13), 4213; https://doi.org/10.3390/jcm12134213 - 22 Jun 2023
Cited by 1 | Viewed by 1046
Abstract
Background: The Myval balloon-expandable (BE) valve has shown encouraging early clinical data in terms of safety and efficacy. Comparative data with other well-established contemporary valves are nonetheless still scarce. This study aims to compare the performance of the Myval BE valve with the [...] Read more.
Background: The Myval balloon-expandable (BE) valve has shown encouraging early clinical data in terms of safety and efficacy. Comparative data with other well-established contemporary valves are nonetheless still scarce. This study aims to compare the performance of the Myval BE valve with the Evolut self-expanding (SE) valve. Methods: In this retrospective single-center study, 223 patients with symptomatic severe aortic stenosis (AS) were included and treated with the Myval BE valve (n = 120) or with the Evolut SE valve (n = 103). Then, 91 pairs were compared after matching. Clinical outcomes were evaluated at 30 days and 1 year. Echocardiographic follow-up was performed at 30 days. Results: Procedural complications were rare in both groups. At the 30-day follow-up, no significant difference in cardiac death (Myval: 1% vs. Evolut: 2%, p = 0.56), stroke (2% vs. 4%, p = 0.41) and myocardial infarction (1% vs. 3%, p = 0.31) was observed. A permanent pacemaker implantation (PPI) was significantly less needed in the Myval group (4% vs. 15%, p = 0.01). At 1 year, cardiac death (2% vs. 4%, p = 0.41) and the stroke rate (7% vs. 5%, p = 0.76) were similar. Moderate–severe paravalvular leakage (PVL) was also comparable in both groups (1% vs. 4%, p = 0.17). Conclusion: Safety and efficacy outcomes were comparable between the two valves, except for a higher PPI rate for the Evolut SE valve. Up to 1-year follow-up, clinical outcomes showed acceptable rates of stroke and cardiac death with both valves. Valve hemodynamics were excellent with a low rate of moderate–severe PVL in both groups. Full article
(This article belongs to the Special Issue Recent Advances in Transcatheter Aortic Valve Replacement)
►▼ Show Figures

Figure 1

Other

Jump to: Research

10 pages, 5312 KiB  
Case Report
Trans-Brachial TAVI in a Patient with Aortic Isthmus Stenosis: A Case Report
by Mohammed Saad, Abdelrahman Elhakim, Rene Rusch, Rouven Berndt, Bernd Panholzer, Georg Lutter and Derk Frank
J. Clin. Med. 2024, 13(2), 308; https://doi.org/10.3390/jcm13020308 - 05 Jan 2024
Viewed by 633
Abstract
Background: TAVI indications expand not only to low-risk patients but also to patients with a more complex anatomy and comorbidities. Transfemoral retrograde access is recognized as the first preferred approach according to the current guidelines. However, this approach is not suitable in up [...] Read more.
Background: TAVI indications expand not only to low-risk patients but also to patients with a more complex anatomy and comorbidities. Transfemoral retrograde access is recognized as the first preferred approach according to the current guidelines. However, this approach is not suitable in up to 10–15% of patients, for whom an alternative non-femoral access route is required. Case Presentation: An 83-year-old male patient with known aortic isthmus stenosis presented with severe symptomatic aortic stenosis. Computed tomography revealed a subtotal isthmus stenosis, directly after left subclavian artery origin, with many collaterals extending toward the axillary and subclavian arteries. Duplex ultrasound verified the proximal diameter of the left brachial artery to be 5.5 mm. A successful surgical cutdown trans-brachial TAVI with an Evolut prosthetic valve with a size of 29 mm was performed. On the fourth postoperative day, the patient was discharged, and the three-month follow-up was uneventful. Conclusion: In patients with aortic isthmus stenosis, the brachial artery could be a feasible alternative, as a less invasive access site, which can be determined after careful assessment of the vessel diameter. More data are required to evaluate the safety and efficacy of this access route and to achieve more technical improvements to increase operator familiarity with it. Full article
(This article belongs to the Special Issue Recent Advances in Transcatheter Aortic Valve Replacement)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-3
Back to TopTop